Ca 2+ Regulation of Ca v 3.3 T-type Ca 2+ Channel Is Mediated by Calmodulin
Molecular Pharmacology, ISSN: 0026-895X, Vol: 92, Issue: 3, Page: 347-357
2017
- 11Citations
- 15Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef10
- Captures15
- Readers15
- 15
Article Description
Calcium-dependent inactivation of high voltage-activated Ca 2+ channels plays a crucial role in limiting rises in intracellular calcium (Ca 2+ i ). A key mediator of these effects is calmodulin, which has been found to bind the C-terminus of the pore-forming α subunit. In contrast, little is known about how Ca 2+ i can regulate low voltage-activated T-type Ca 2+ channels. Using whole cell patch clamp, we examined the biophysical properties of Ca 2+ current through the three T-type Ca 2+ channel isoforms, Ca v 3.1, Ca v 3.2, or Ca v 3.3, comparing internal solutions containing 27 nM and l μM free Ca 2+. Both activation and inactivation kinetics of Ca v 3.3 current in l μM Ca 2+ i solution were more rapid than those in 27 nM Ca 2+ i solution. In addition, both activation and steady-state inactivation curves of Ca v 3.3 were negatively shifted in the higher Ca 2+ i solution. In contrast, the biophysical properties of Ca v 3.1 and Ca v 3.2 isoforms were not significantly different between the two internal solutions. Overexpression of CaM 1234 (a calmodulin mutant that doesn’t bind Ca 2+ ) occluded the effects of l μM Ca 2+ i on Ca v 3.3, implying that CaM is involved in the Ca 2+ i regulation effects on Ca v 3.3. Yeast two-hybrid screening and co-immunoprecipitation experiments revealed a direct interaction of CaM with the carboxyl terminus of Ca v 3.3. Taken together, our results suggest that Ca v 3.3 T-type channel is potently regulated by Ca 2+ i via interaction of Ca 2+ /CaM with the carboxyl terminus of Ca v 3.3.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0026895X24006515; http://dx.doi.org/10.1124/mol.117.108530; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85028640408&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28696213; https://linkinghub.elsevier.com/retrieve/pii/S0026895X24006515; https://dx.doi.org/10.1124/mol.117.108530; https://molpharm.aspetjournals.org/content/92/3/347
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know